Procalcitonin Kinetics for Assessing 30-Day Mortality Risk in Cirrhotic Patients With SIRS: Opportunities and Limitations
Open Access
- 17 November 2025
- journal article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 16 (12) , e00940
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Procalcitonin as a Predictive Marker of Incident Liver DiseaseLiver International, 2025
- Serial Procalcitonin Measurements for Determining Bacterial Infection and Mortality in Cirrhotic Patients With Systemic Inflammatory Response SyndromeClinical and Translational Gastroenterology, 2024
- The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver FailureJournal of Clinical Medicine, 2022
- Procalcitonin and Liver Disease: A Literature ReviewJournal of Clinical and Translational Hepatology, 2018
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosisJournal of Hepatology, 2018